At this year's American College of Cardiology (ACC) annual meeting, Toshiba will be showcasing its full line of CT products from multi-detector to dynamic volume systems. The Aquilion® product line has been instrumental in worldwide, multi-center clinical trials to validate the effectiveness of CT in improving the lives of patients. Recently, results were announced for the CorE 64 multicenter trial, and Toshiba launched support of a new trial - CORE 320 - to validate the Aquilion ONE. In addition to both of these, Toshiba will also have information about the faCTor64 trial being conducted at Intermountain Healthcare in Utah.

In addition, Toshiba will demonstrate automated workflow enhancements and clinical applications for the Aquilion CT line -SURECardio Prospective and Variable Helical Pitch (vHP) - designed to manage and reduce patient radiation dose, provide faster diagnosis and maximize patient comfort.

SURECardio Prospective
Toshiba's SURECardio Prospective helps reduce patient radiation dose by up to 80 percent during coronary CTA exams by using a helical acquisition technique to provide one continuous image instead of multiple images produced by the current step-and-shoot technique. The step-and-shoot technique can produce inconclusive images, particularly for patients with irregular heartbeats, leading to increased exam times and radiation dose for the patient. SURECardio Prospective will automatically adjust to patients with irregular heartbeats, providing quicker, more conclusive exam results.

SURECardio Prospective automatically selects scan parameters and reconstruction based on the patient's heart rate. It also speeds exam time and eliminates the need for additional contrast used with the step-and-shoot method.

Variable Helical Pitch
Variable Helical Pitch (vHP) increases workflow and efficiency by enabling physicians to complete an exam of more than one anatomical region consecutively - i.e. without stopping to alter the helical pitch of the exam. This gives physicians the flexibility needed for cardiovascular imaging. For example, patients with suspected chest pain can now undergo one CT exam that provides physicians information to assist in the diagnosis of both heart disease and aortic aneurysms.

Toshiba is the first to clinically introduce this type of technique.

Magnetic Resonance
Toshiba to Demonstrate Virtual Explorer Workstation
3D MR Workstation Offers Unmatched Cardiac Evaluation Capabilities

More HCB News